As it is, Atcor is the only company with FDA approval for measuring central blood pressure (cBP) using it's algorithm with a cuff. The only other way for a cBP reading is via a catheter in the hospital. The blood pressure at the heart(cBP) is different to that taken by standard blood pressure equipment and considered more accurate at predicting a health condition or pre empting a stroke or heart attack. This algorithm can also give a pulse wave velocity reading and arterial stiffness reading. Again the only FDA approved device. These readings are also used to adjust medication as it has accurate readings.
The holy grail is a sensor based reading which no device or watch it any company can claim from a clinical point of view.
Cardiex is primed to be the pioneer here at being the only company with the whole kit and kaboodle
Partnering with blumio, mobvoi and infeon should achieve this
There was an Ann a while back which said something about it being a world first I think from the trial it did with Macquarie University from memory. I can't remember but you'll have to read it.
Ive been tested on the device at the old Atcor offices a few years ago with my ICU nurse wife.
That device gives a print out of all your readings from the computer.
This is the device used with the world's Top 20 hospitals, the contracts in use with major pharmaceutical companies in the past and current in the trial division of Atcor ( bread and butter revenue), over 4000 + peer reviews in papers and one of only a few companies in the world to have it's own cpt reimburse code in the US
Once we get Medicare reimbursement the rivers of cash should be massive here
- Forums
- ASX - By Stock
- CDX
- Ann: Results of Share Purchase Plan
CDX
cardiex limited
Add to My Watchlist
0.00%
!
4.0¢

Ann: Results of Share Purchase Plan, page-34
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.94M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 0.039 |
3 | 340000 | 0.038 |
4 | 657100 | 0.037 |
2 | 263210 | 0.036 |
3 | 365503 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 60000 | 1 |
0.045 | 202414 | 3 |
0.050 | 100000 | 1 |
0.052 | 180000 | 1 |
0.080 | 100799 | 1 |
Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online